A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Condition: Irritable Bowel Syndrome Interventions: Drug: 25mg Eluxadoline; Drug: 100mg Eluxadoline Sponsor: Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials